Erectile dysfunction: Is platelet-rich plasma the new frontier for treatment in patients with erectile dysfunction? A review of the existing evidence

Journal List Front Reprod Health PMC9580815 As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC Copyright Notice Front Reprod Health. 2022; 4: 944765. Published online 2022 Aug 16. doi:10.3389/frph.2022.944765PMCID: PMC9580815PMID: 36303622Eleni Anastasiadis,1,* Razna Ahmed,2 Abbas Khizar Khoja,2 and Tet Yap2,3Author information Article notes Copyright and License information PMC DisclaimerAbstractErectile dysfunction (ED) is one of the commonest disorders in adult males and affects 12–19% of men of reproductive age. Only few studies have evaluated the impact of ED on men and couples with infertility—these studies report higher rates of ED in this sub-group of men compared to the general population, with the prevalence of ED in men diagnosed with male infertility ranging from 6.7 to 61.6%. Nevertheless, ED is c...